SCHEMBL13743571

SCHEMBL13743571

OC[C@@H](O)[C@@H](Oc1ccccc1)c1ccccc1

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SLC6A4 P31645 1/20 0.39
MTNR1A P48039 1/20 0.38
MTNR1B P49286 1/20 0.38
LMNA P02545 2/20 0.37
ALDH1A1 P00352 1/20 0.36
RECQL P46063 1/20 0.36
SCN4A P35499 2/20 0.36
TRPA1 O75762 2/20 0.36
GSR P00390 1/20 0.36
KDM4E B2RXH2 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
LTA4H P09960 1/20 0.34
SRD5A2 P31213 1/20 0.34
MEN1 O00255 1/20 0.34
OPRM1 P35372 1/20 0.34
OPRD1 P41143 1/20 0.34
KMT2A Q03164 1/20 0.34
FFAR1 O14842 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27906584 1.00 SLC6A4 (0.39) SLC6A4MTNR1AMTNR1BLMNAALDH1A1
SCHEMBL7197530 0.89 SLC6A4 (0.37) SLC6A4LMNAALDH1A1RECQLSCN4A
SCHEMBL13743579 0.83 SLC6A4 (0.44) SLC6A4SCN4A
SCHEMBL11406412 0.83 SLC6A4 (0.44) SLC6A4SCN4A
SCHEMBL502622 0.82 LMNA (0.40) SLC6A4LMNAALDH1A1TRPA1GSR
E968 SCHEMBL8463462 0.81 ACP3 (0.39) ALDH1A1
SCHEMBL13743580 0.80 SCN4A (0.41) SLC6A4LMNAALDH1A1RECQLSCN4A
SCHEMBL10338422 0.80 THRB (0.46) SLC6A4LMNAALDH1A1TRPA1GSR
SCHEMBL13743855 0.79 TRPA1 (0.44) SLC6A4MTNR1AMTNR1BLMNAALDH1A1
SCHEMBL5307465 0.79 SLC6A4 (0.49) SLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090198080-A1 METHOD FOR THE PREPARATION OF ARYL ETHERS PFIZER INC 2009-08-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090198080-A1 METHOD FOR THE PREPARATION OF ARYL ETHERS CYP2E1, CBR1, CYP1A1 SLC6A4 2765/4885MTNR1A 170/4885MTNR1B 154/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.